{"url_path":"/sec/bcda/8-k/2026-06-08/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 **   **Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-08","source_url":"https://www.sec.gov/Archives/edgar/data/925741/0001437749-26-019789-index.html","accession_number":"0001437749-26-019789","cik":"0000925741","ticker":"BCDA","issuer_name":"BioCardia, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/925741/0001437749-26-019789-index.html","primary_entity_key":"0000925741","primary_entity_name":"BioCardia, Inc."},"word_count":153,"has_tables":true,"body_markdown":"**Item 8.01**   **Other Events.**\n\n \n\nOn June 8, 2026, BioCardia, Inc. (the “Company”) issued a press release announcing that the Company sold 3,509,604 shares at an average price of $1.279 on Friday, June 5, 2026. The shares were sold pursuant to the Company’s “At The Market” offering agreement with H.C. Wainwright & Co.\n\n \n\nA copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.\n\n \n\nThe information in this Item 8.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing."}